1. Serey-Gaut, Margaux, Cortes, Marisol, Makrythanasis, Periklis, Dawson, Ted M, Antonarakis, Stylianos E. 2023. Bi-allelic TTI1 variants cause an autosomal-recessive neurodevelopmental disorder with microcephaly. In American journal of human genetics, 110, 499-515. doi:10.1016/j.ajhg.2023.01.006. https://pubmed.ncbi.nlm.nih.gov/36724785/
2. Xu, Peng, Du, Guangsheng, Guan, Haidi, Sun, Lihua, Yang, Hua. . A role of TTI1 in the colorectal cancer by promoting proliferation. In Translational cancer research, 10, 1378-1388. doi:10.21037/tcr-20-3322. https://pubmed.ncbi.nlm.nih.gov/35116463/
3. Zhang, Ling-Xian, Yang, Xin, Wu, Zhi-Bo, Wu, Yong-Bing, Zhu, Shu-Qiang. 2022. TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway. In Cancer science, 114, 855-869. doi:10.1111/cas.15668. https://pubmed.ncbi.nlm.nih.gov/36403197/
4. Yang, Hui, Wang, Xinzhi, Blanco-Gómez, Adrián, Perez-Losada, Jesus, Mao, Jian-Hua. 2024. A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice. In EBioMedicine, 106, 105260. doi:10.1016/j.ebiom.2024.105260. https://pubmed.ncbi.nlm.nih.gov/39067134/
5. Katoh-Fukui, Yuko, Hattori, Atsushi, Zhang, Ruogu, Matsuura, Nobuo, Fukami, Maki. . Chromosomal microdeletion leading to pituitary gigantism through hormone-gene overexpression. In Human molecular genetics, 32, 2318-2325. doi:10.1093/hmg/ddad053. https://pubmed.ncbi.nlm.nih.gov/37070740/
6. Buttarelli, Marianna, Ciucci, Alessandra, Palluzzi, Fernando, Scambia, Giovanni, Gallo, Daniela. 2022. Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients. In Journal of experimental & clinical cancer research : CR, 41, 50. doi:10.1186/s13046-022-02265-w. https://pubmed.ncbi.nlm.nih.gov/35120576/